Eli Lilly Reaffirms Outlook; Expects to Maintain Dividend (LLY)

Eli Lilly Reaffirms Outlook; Expects to Maintain Dividend (LLY)

RSS

Eli Lilly & Co. (LLY) reported that it plans on returning to revenue growth and expanding margins in 2014..

The company is now preparing to introduce new medicines in the beginning of next year, which will allow it to increase revenue and expand its margins. LLY reported that it plans to offset a loss of revenue from patent expirations using targeted growth initiatives and expense controls.

Looking forward, the company has maintained its near-term estimate of obtaining at least $20 billion in revenue, $3 billion in net income and $4 billion in operating cash flow through 2014.

LLY also noted that it expects to maintain its current dividend and reported that it would supplement its annual dividend of $2 billion per year with share buybacks of about $5 billion.

Eli Lilly shares were down 64 cents, or 1.27%, during pre-market trading Thursday. The stock has been mostly flat YTD.

The Bottom Line

Shares of Eli Lilly & Co. (LLY) have a 3.88% yield based on Wednesday’s closing price of $50.54.

Eli Lilly & Co. (LLY) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from Dividend.com.

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today